$0.15
0.00 (+0.07%)
Cortex Pharmaceuticals (COR)
CAPS Rating:
The Company is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

RSS Headlines
Fool UK